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ScienceDirectCapturing norovirus transmission
Miranda de Graaf, Nele Villabruna and Marion PG KoopmansHuman norovirus is a leading cause of gastroenteritis and is
efficiently transmitted between humans and around the globe.
The burden of norovirus infections in the global community and
in health-care settings warrant the availability of outbreak
prevention strategies and control measures that are tailored to
the pathogen, outbreak setting and population at risk. A better
understanding of viral and host determinants of transmission
would aid in developing and fine-tuning such efforts. Here, we
describe mechanisms of transmission, available model
systems for studying norovirus transmission and their strengths
and weaknesses as well as future research strategies.
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Human norovirus (HuNV) has been described as the
perfect human pathogen due to its ability to replicate to
high titers, its low infectious dose and high stability in the
environment [1]. HuNV belongs to the family Calicivir-
idae and is the most prevalent viral cause of gastroenteritis
cases and outbreaks worldwide, leading to significant
morbidity and mortality [2–4]. To be maintained in the
human population, it has to overcome environmental
barriers as well as structural, functional and immunological
barriers within the host, and undergo a full replication
cycle leading to the formation and release of new infec-
tious virus particles. Next, these newly formed virus
particles have to result in infection of additional cells
within the same host and/or shedding from the host.
Finally, the viral particles need to be transmitted to a
new host, which occurs through the fecal-oral or oral-oral
route. Transmission can be direct (person-to-person) or
indirect through fecal or vomit contamination of food,
water, fomites and the environment [5,6,7–9].Current Opinion in Virology 2017, 22:64–70The norovirus (NV) genus can be subdivided in seven
genogroups, of which genogroups GI, GII and GIV have
been detected in humans, and can be further subdivided
into more than 40 genotypes [10]. These genotypes are
not equally prevalent as causes of disease in humans:
currently most gastroenteritis outbreaks are caused by the
GII.4 genotype, although in some parts of Asia GII.17
recently emerged as the predominant genotype [11–13].
While the dynamics of GII.4 circulation are thought to be
influenced by virus evolution and population immunity, it
is not clear why this particular genotype is more success-
ful than others in causing outbreaks and spreading around
the globe. This is partly because much of our knowledge
on NV transmission is based on epidemiological observa-
tions, rather than on controlled in vitro or in vivo experi-
ments. Similarly, many other questions have remained
unanswered. For example, what is the effect of antigenic
evolution or recombination on norovirus fitness and trans-
missibility. What is the size and nature of genetic bottle-
necks during transmission events? And what proportion of
viruses that we can detect in a clinical or environmental
setting are actually infectious and able to transmit? As
major advances have been made in recent years, we
review the currently available tools and models to study
norovirus transmission in vitro and in vivo.
Evidence from epidemiological studies and
outbreak investigations
Epidemiological studies have demonstrated that the con-
tributions of the individual genogroups and genotypes
can vary among outbreak settings and transmission routes
(Figure 1) [14]. For example, norovirus outbreaks caused
by the GII.4 genotype are more common in health-care
facilities than outbreaks caused by GI and non-GII.4
genotypes. Within health-care facilities GII.4 strains
are more often associated with outbreaks in adult wards
and GII.3 strains with outbreaks in children wards. In
hospitals the dominant transmission route is from patient-
to-patient followed by patient-to-health-care worker and
is related to level of dependency [15,16]. In community
outbreaks young children (<5 years) are more likely to
infect other people compared to older children, possibly
because they have relatively high rates of contact and low
levels of hygiene [17–19]. Persons can be infected with
HuNV without the presentation of symptoms [20], but
the relationship between shedding and disease is not clear
with some conflicting evidence in literature [4,21].
However, in health-care settings, symptomatic patients
were found to be responsible for the majority of trans-
mission events [22]. In all, epidemiological studies have
also provided some information on differences in trans-
mission efficiency between genotypes, but it is difficult towww.sciencedirect.com
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HuNV tropism and transmission. After shedding from the host via vomitus or feces HuNV is transmitted to the next host. Transmission can
occur through several routes, with differences in association between genogroup and transmission route [68]. During transmission, viruses
encounter multiple environmental barriers and as well as structural, functional and immunological barriers within the host that can potentially
restrict or prevent transmission. After infection of the new host HuNV replicates in the intestine. In immunocompromised patients HuNV antigens
can be detected in the ileum, jejunum and duodenum in enterocytes, macrophages, T cells and dendritic cells [25]. The inset shows the detection
of RdRp and VP1 (yellow arrows) in the same duodenal biopsy from a HuNV positive patient (adapted from [25]).obtain conclusive evidence without the use of in vitro and
in vivo (transmission) model systems.
In vitro cell culture systems
Historically, norovirus transmission studies have been
hindered by the lack of cell culture models. Noroviruses
attach to human cells through the (co)-receptor histo-blood
group antigens (HBGA) and a recent study demonstrated
that HuNV productively infects B cells, in the presence of
exogenous HBGA or HBGA-like molecules on specificwww.sciencedirect.comintestinal bacteria [23,24]. In biopsies obtained from
HuNV infected immunocompromised persons, the major
capsid protein (VP1) was detected in enterocytes, macro-
phages, T cells and dendritic cells. HuNV replication was
investigated by the detection of the non-structural proteins
RNA-dependent RNA polymerase (RdRp) and the ge-
nome associated VPg. Both were detected alongside VP1
in duodenal and jejunal enterocytes [25] (Figure 1). In
agreement with these findings successful cultivation
of multiple HuNV strains in human intestinal enteroidCurrent Opinion in Virology 2017, 22:64–70
66 Emerging viruses: interspecies transmissionmonolayers was recently reported [26]. Bile was required
for replication of some strains, while the lack of appropriate
HBGA restricted replication.Ex vivo inoculation of human
duodenal tissues with GII.4 isolates also resulted in an
increase of viral genomic RNA over time and expression of
both structural and non-structural proteins in glandular
epithelial cells [27]. These HuNV cell culture models can
be used study HuNV replication kinetics, virus–host inter-
actions and other aspects of NV biology and will finally
allow researches to address many of the unanswered
questions listed above.
But what are the minimal requirements for a cell culture
system to be a valuable tool for HuNV transmission
studies? The HuNV cell culture system has to support
attachment, internalization, replication and release of the
viral particles, but is it necessary to include the micro-
biome? To study the role of bacteria, transwell cultures
can be used where the viruses and bacteria are added to
the apical or basolateral sides of the cell culture [28].
However, these infection models are not suitable for co-
culturing with a living microbiome for prolonged periods
of time, because of rapid bacterial overgrowth, which is a
major limitation to their use. In the future, the gut-on-
chip system could potentially mimic the normal epithelial
differentiation in the gut ecosystem, in which peristalsis
and flow of intestinal content restrain microbial over-
growth in vivo [29].
Experimental transmission models
HuNV infection and transmission events can be studied in
vivo by the use of human volunteers, experimental ani-
mals or animal caliciviruses in their natural hosts. Several
experimental animal models support HuNV replication;
chimpanzees, immunocompromised mice, gnotobiotic
pigs and gnotobiotic calves [30–34]. Most of these animal
models can be infected with HuNV by oral inoculation.
Despite the apparent stability of NV in an acidic envi-
ronment [35], formost of these studies sodiumbicarbonate
is orally administered prior to virus inoculation to neutral-
ize stomach acids and increase infection efficiency. The
immunocompromised BALB/c Rag-gc mice are an excep-
tion as they require an intraperitoneal route of infection,
which is not ideal for transmission studies [32].
Pigs are natural hosts for NV genotypes GII.11, GII.18
and GII.19 [10,36,37], while bovine species are natural
hosts for GIII strains [38]. One study reports the detection
of GII.4 in pigs and cattle from farms [37] and inoculation
of both gnotobiotic pigs and calves with GII.4 results in
replication [31]. However, these animal models are chal-
lenging due to size of the animals and costs. Replication
in the gnotobiotic pig model occurs in the small intestine
and results in virus shedding and diarrhea [39]. Contami-
nated oysters can be a source of foodborne HuNV infec-
tion in humans and this can be mimicked in gnotobiotic
pigs as they can be infected by feeding them HuNVCurrent Opinion in Virology 2017, 22:64–70seeded oyster homogenates [40]. In immunocompro-
mised patients, HuNV infection can result in prolonged
shedding and more severe disease, raising questions
about the role of such persons in the emergence and
transmission of HuNV [41]. Recently an immunocompro-
mised gnotobiotic pig model was developed; these
RAG2/IL2RG deficient pigs were characterized by de-
pletion of lymphocytes and either absence of or structur-
ally abnormal immune organs [42]. Similar to what was
observed for immunocompromised patients, infection
with GII.4 led to increased viral titers and prolonged
virus shedding compared to wild-type pigs. An intriguing
observation was that the use of a common treatment with
cholesterol lowering drugs affected severity in humans,
and HuNV replication in pigs [43,44]. These results
suggest that the gnotobiotic pig model is a suitable model
to study foodborne transmission and transmission events
involving immunocompromised patients. Co-infections
with HuNV and HBGA-expressing Enterobacter cloacae
were also investigated in the gnotobiotic pig model, but
surprisingly and in contrast to the in vitro observations
[45], co-inoculation with Enterobacter cloacae inhibited
HuNV infectivity in pigs [46].
Chimpanzees can be infected with GI.1 HuNV by the
intravenous and oral route [33,34]. Infection does not
result in diarrhea or histopathological changes of the
gut tissue, although the duration and titers of HuNV
shedding in feces resembles that in humans [34]. The
virus could be passaged from chimpanzee-to-chimpanzee
by feeding of fecal filtrate [33]. Notably, chimpanzees
that were not challenged but were located in the same and
adjacent rooms developed antibody responses, although
HuNV antigen could not be detected in their feces [33].
However, chimpanzees are no longer available for bio-
medical research due to ethical reasons. Human GII.4
strains also have been detected in dogs and, surprisingly,
canine seroprevalence to different HuNV genotypes
resembles the seroprevalence in the human population
[47,48]. However, to date experimental infections of dogs
with HuNV have not been documented.
The murine norovirus (MNV) model has been used to
study many aspects of the NV replication cycle [49]. MNV
belongs to genogroup GV and replicates to high titers in
vitro and in vivo in its natural host [49,50]. MNV and other
cultivable caliciviruses such as Tulane virus (genus Reco-
virus) and feline calicivirus (genus Vesivirus) have been
used as HuNV surrogates for inactivation studies, to either
prevent transmission and control outbreaks or to increase
food safety [51]. However, the value of these model
organisms needs to be assessed on a case by case basis,
depending on the question addressed as there can be
differences in, amongst others, receptor usage and trans-
mission routes [51]. These studies can also be performed
with HuNV; the degradation of virus particles can be
assessed by determining the change in viral RNA copieswww.sciencedirect.com
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Mice model for contact transmission Mice, deficient in INF-a/b and IFN-g receptors were infected with MNV (green). Uninfected sentinel mice
(purple) were placed with the infected donor mice (a) or in a contaminated environment in absence of the infected donor animals (b), both settings
resulted in infection of the sentinel mice. Donor animals were treated with 2CMC (syringe) prior to inoculation with MNV and placed with sentinel
animals, seven days post inoculation (dpi) 2CMC treatment was discontinued and both groups were placed in separate cages (c). The 2CMC
treatment impacted on disease and transmission [53].
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68 Emerging viruses: interspecies transmissionor binding properties [52], but such assays do not always
accurately represent infectious titers. A transmission mod-
el for MNV was developed by Rocha-Pereia et al. [53]
(Figure 2). Donor animals were inoculated with MNV and
placed into the same cage as uninfected sentinel animals.
Alternatively, the sentinel animals were placed in a con-
taminated environment in absence of the infected donor
animals (Figure 2a and b). In the absence of antivirals,
both strategies resulted in infection of the sentinel ani-
mals. Using this model, it was demonstrated that treat-
ment of the donor or sentinel animals with the antiviral 2’-
C-methylcytidine (2CMC) prevented transmission and
reduced disease severity (Figure 2c). Thus, the mice
model provides a valuable tool for future transmission
studies and could be useful to address many of the current
‘unknowns’ of NV transmission, such as the relation
between replication kinetics and transmission or the size
and nature of genetic bottlenecks duringNV transmission.
Clinical symptoms and transmission
It is likely that in the absence of clinical symptoms such as
vomiting and diarrhea, transmission events are infrequent
due to the lack of environmental contamination. Vomit-
ing and toilet flushing can result in the formation of
droplets and aerosols [54], and several studies have been
dedicated to elucidate the role of vomiting in transmis-
sion through the airborne route and by environmental
contamination. Initial indication for the possible role of
vomiting in transmission came from outbreak investiga-
tions where the secondary attack rate of NV was inversely
correlated to the distance of the contact to a person
vomiting inside a confined space [55]. Human challenge
studies with GI.1, GII.2 and GII.1 strains demonstrated
that 40–100% of the infected subjects vomited at least
once. Most of the emesis samples contained detectable
virus titers with mean titers of 8.0  105 and 3.9  104
genomic equivalent copies/ml for GI and GII viruses,
respectively. A second factor is the severity of vomiting,
described as projectile vomiting with abrupt onset. The
force of emesis may affect the dispersal of droplets and
aerosols and thereby the severity of environmental con-
tamination. To assess the extent to which an episode of
projectile vomiting can contaminate the environment a
simulated vomiting system named Vomiting Larry was
developed [56]. The model is based on the intragastric
pressures, that reaches on average 10.93 kPa and can be as
high as 38.66 kPa during vomiting, as measured during
episodes of vomiting induced in volunteers by drinking
Ipecac syrup [57]. Simulation studies with Vomiting
Larry indicated that during an episode of projectile
vomiting splashes and droplets can spread >3 m forward
and 2.6 m lateral and that an area of at least 7.8 m2 should
be decontaminated [56]. Others were able to generate
aerosols with the HuNV surrogate bacteriophage MS2
[58]. More importantly aerosolized HuNV genomes could
be detected during outbreaks in health-care facilities
with concentrations ranging from 1.4  101 to 2.4  103Current Opinion in Virology 2017, 22:64–70genome copies perm3 of air. That infectivity and integrity
of NV particles can be preserved during aerosolization
was shown with MNV [59]. Considering the low infec-
tious dose needed to infect volunteers [3], these concen-
trations would likely be high enough to infect new hosts
after inhalation and swallowing of the viral particles.
Stability in the environment
After shedding from the host NV particles have to remain
stable in the environment prior to infecting a new host.
The presence of bacteria can affect viral stability, for
example binding of poliovirus to bacterial surface poly-
saccharides enhances virion stability [45,60]. In the pres-
ence of bacteria MNV was more stable to electrical
breakdown in water [61], while HuNV was found to
be more stable to acute heat stress. Thus, the presence of
bacteria might facilitate transmission owing to an increase
in stability in the environment.
GII.4 strains have the highest prevalence in the winter
season in temperate regions. For influenza it is thought
that seasonality is related to stability and humidity as
humidity can negatively affect transmission efficiency in
vivo [62]. High humidity also resulted in a decrease of
infectivity and binding capacity of MNV and HuNV,
respectively [63], while low humidity, like observed
during the winter, was beneficial toNV survival. Although
it should be noted that for non-GII.4 genotypes and in
non-temperate regions seasonality is less clear [64]. De-
spite its sensitivity to humidity, HuNV is very stable in
water. It was demonstrated that ground water spiked to a
final concentration of 6.5  107 GI.1 HuNV genomic
equivalent copies/ml remained infectious to humans for
at least 61 days. Remarkably, HuNV genome copies
remained detectable in groundwater for over three years,
although it was not assessed whether these represented
infectious virus [65]. In this study the infectivity was
evaluated using human volunteers. The availability of the
HuNV cell culture system will make it easier to deter-
mine what proportion of viruses that we can detect in the
environment are infectious. Of interest, GI noroviruses
have a higher association with waterborne infections
compared to GII viruses and it is hypothesized that this
is the result of a higher stability in water [8,66], and
limited removal efficiency during sewage treatment [67].
Conclusion
Despite major hurdles in culturing HuNV and the devel-
opment of animal models, considerable progress has been
made in understanding NV transmission. However, it is
anticipated that the recent availability of cell culture
systems and animal models will uncover many of the
current ‘unknowns’ and will boost the development of
vaccines, antivirals and treatment strategies. A better un-
derstanding of HuNV transmission and the development
of outbreak control protocols and HuNV inactivation tech-
niques will likely improve food safety and health-care.www.sciencedirect.com
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